In 2025, Novo Nordisk was pushed to cut its sales forecasts for Wegovy, explicitly blaming the rise in compounded alternatives for lost revenue and a sharp decline in its share price
Rising ghrelin levels during weight loss can partially counteract retatrutide's appetite-suppressing effects as a physiological counter-regulatory response
Deciphering the conformations of glutathione oxidized peptide: a comparative NMR study in solution and solidstate environments
Wegovy has been approved by the HSA for chronic weight management since 2023, and from late 2025 clinics and telehealth providers have been prescribing it and tirzepatide at scale
This kind of personalized, phase-based approach requires understanding the full toolkit
Long-term PCOS care also means nourishing your body with good food, moving in ways you enjoy, and caring for your emotional well-being